Antitumor effect of adenovirus-mediated Bax gene transfer on p53- sensitive and p53-resistant cancer lines

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1157-1161

  Kagawa, Shunsuke ^a   Gu, Jian ^a   Swisher, Stephen G ^a   Ji, Lin ^a   Roth, Jack A ^a   Lai, Dejian ^b   Stephens, L Clifton ^a   Fang, Bingliang ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GENES, P53; GENETIC VECTORS; HUMANS; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0034163805     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Levine, E. L., Davidson, S. E., Roberts, S. A., Chadwick, C. A., Potten, C. S., and West, C. M. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet, 344: 472, 1994.
2. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
3. Xiang, J., Chao, D. T., and Korsmeyer, S. J. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA, 93: 14559-14563, 1996.
4. Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., and Korsmeyer, S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (Washington DC), 270: 96-99, 1995.
5. Gil, J., Yamamoto, H., Zapata, J. M., Reed, J. C., and Perucho, M. Impairment of the proapoptotic activity of Bax by missense mutations found in gastrointestinal cancers. Cancer Res., 59: 2034-2037, 1999.
6. Yin, C., Knudson, C. M., Korsmeyer, S. J., and Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature (Lond.), 385: 637-640, 1997.
7. Krajewski, S., Blomqvist, C., Franssila, K., Krajewska, M., Wasenius, V. M., Niskanen, E., Nordling, S., and Reed, J. C. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55: 4471-4478, 1996.
8. Sakakura, C., Sweeney, E. A., Shirahama, T., Igarashi, Y., Hakomori, S., Tsujimoto, H., Imanishi, T., Ogaki, M., Ohyama, T., Yamazaki, J., Hagiwara, A., Yamaguchi, T., Sawai, K., and Takahashi, T. Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide. Surg. Today (Tokyo), 27: 676-679, 1997.
9. Tai, Y. T., Lee, S., Niloff, E., Weisman, C., Strobel, T., and Cannistra, S. A. BAX protein expression and clinical outcome in epithelial ovarian cancer [see comments]. J. Clin. Oncol., 16: 2583-2590, 1998.
10. Strobel, T., Kraeft, S. K., Chen, L. B., and Cannistra, S. A. BAX expression is associated with enhanced intracellular accumulation of paclitaxel: a novel role for BAX during chemotherapy-induced cell death. Cancer Res., 58: 4776-4781, 1998.
11. Kagawa, S., Pearson, S. A., Ji, L., Xu, K., McDonnell, T. J., Swisher, S., Roth, J. A., and Fang, B. A binary adenoviral vector for expressing high levels of the proapoptotic gene bax. Gene Ther., 7: 75-79, 2000.
12. Ji, L., Bouvet, M., Price, R. E., Roth, J. A., and Fang, B. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1, E3 and inactivated E4 by GAL4-TATA promoter replacement. Gene Ther., 6: 393-402, 1999.
13. Fang, B., Ji, L., Bouvet, M., and Roth, J. A. Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery. J. Biol. Chem., 273: 4972-4975, 1998.
14. Roehm, N. W., Rodgers, G. H., Hatfield, S. M., and Glasebrook, A. L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods. 142: 257-265, 1991.
15. Spitz, F. R., Nguyen, D., Skibber, J. M., Meyn, R. E., Cristiano, R. J., and Roth, J. A. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin. Cancer Res., 2: 1665-1671, 1996.
16. Harris, M. P., Sutjipto, S., Wills, K. N., Hancock, W., Cornell, D., Johnson, D. E., Gregory, R. J., Shepard, H. M., and Maneval, D. C. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther., 3: 121-130, 1996.
17. Coll, J. L., Negoescu, A., Louis, N., Sachs, L., Tenaud, C., Girardot, V., Demeinex, B., Brambilla, E., Brambilla, C. and Favrot, M. Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis. Hum. Gene Ther., 9: 2063-2074, 1998.
18. Kovesdi, I., Brough, D. E., Bruder, J. T., and Wickham, T. J. Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol., 8: 583-589, 1997.
19. Tai, Y. T., Strobel, T., Kufe, D., and Cannistra, S. A. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. Cancer Res., 59: 2121-2126, 1999.
20. Le Chevalier, T., Arriagada, R., Quoix, E., Ruffie, P., Martin, M., Tarayre, M., Lacombe-Terrier, M. J., Douillard, J. Y., and Laplanche, A. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients [see comments]. J. Natl. Cancer Inst., 83: 417-423, 1991.